Teva Pharmaceuticals @TevaUSA
Christine Baeder, SVP, COO for US Generics at Teva and AAM Vice Chair shares a recap of the exciting happenings at #GRxBiosims 2022. She sat down with AAM to discuss the regulatory environment and the need for collaboration to pave the way for complex generics and biosimilars. — PolitiTweet.org
AAM @AccessibleMeds
"It's an exciting time to gather at GRx+Biosims 2022. No one mind can solve our problems, it really takes people co… https://t.co/XKoTv2Oh8U